24 related articles for article (PubMed ID: 38500386)
1. NICD3 regulates the expression of MUC5AC and MUC2 by recruiting SMARCA4 and is involved in the differentiation of mucinous colorectal adenocarcinoma.
Yan X; Cheng Y; Zhang X; Hu Y; Huang H; Ren J; Wen B; Yang Y; Xiao K; Hu W; Wang W
Mol Oncol; 2022 Oct; 16(19):3509-3532. PubMed ID: 35900231
[TBL] [Abstract][Full Text] [Related]
2. PLAGL2 and POFUT1 are regulated by an evolutionarily conserved bidirectional promoter and are collaboratively involved in colorectal cancer by maintaining stemness.
Li D; Lin C; Li N; Du Y; Yang C; Bai Y; Feng Z; Su C; Wu R; Song S; Yan P; Chen M; Jain A; Huang L; Zhang Y; Li X
EBioMedicine; 2019 Jul; 45():124-138. PubMed ID: 31279780
[TBL] [Abstract][Full Text] [Related]
3. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
[TBL] [Abstract][Full Text] [Related]
4. SCF/c-KIT Signaling Increased Mucin2 Production by Maintaining Atoh1 Expression in Mucinous Colorectal Adenocarcinoma.
Shen P; Yang S; Sun H; Li G; Wu B; Ji F; Sun T; Zhou D
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29786668
[TBL] [Abstract][Full Text] [Related]
5. MUC2 expression in primary mucinous and nonmucinous adenocarcinoma of the prostate: an analysis of 50 cases on radical prostatectomy.
Osunkoya AO; Adsay NV; Cohen C; Epstein JI; Smith SL
Mod Pathol; 2008 Jul; 21(7):789-94. PubMed ID: 18487999
[TBL] [Abstract][Full Text] [Related]
6. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects.
Debunne H; Ceelen W
Acta Chir Belg; 2013; 113(6):385-90. PubMed ID: 24494463
[TBL] [Abstract][Full Text] [Related]
7. Consequence of distinctive expression of MUC2 in colorectal cancers: How much is actually bad?
Gundamaraju R; Chong WC
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188579. PubMed ID: 34139275
[TBL] [Abstract][Full Text] [Related]
8. Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer.
Huang A; Yang Y; Shi JY; Li YK; Xu JX; Cheng Y; Gu J
World J Gastrointest Surg; 2021 Dec; 13(12):1567-1583. PubMed ID: 35070064
[TBL] [Abstract][Full Text] [Related]
9. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options.
Luo C; Cen S; Ding G; Wu W
Cancer Commun (Lond); 2019 Mar; 39(1):13. PubMed ID: 30922401
[TBL] [Abstract][Full Text] [Related]
10. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis.
Verhulst J; Ferdinande L; Demetter P; Ceelen W
J Clin Pathol; 2012 May; 65(5):381-8. PubMed ID: 22259177
[TBL] [Abstract][Full Text] [Related]
11. POFUT1 and PLAGL2 are characteristic markers of mucinous colorectal cancer associated with MUC2 expression.
Monno M; Ogiri M; Seishima R; Suzuki Y; Hattori K; Matsui S; Shigeta K; Okabayashi K; Kitagawa Y
Cell Biochem Funct; 2024 Mar; 42(2):e3989. PubMed ID: 38500386
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
